Sign In
Buy SYK
$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
04:30pm, Wednesday, 13'th Mar 2024
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain
Stryker (SYK) Completes First Arthroplasty Surgery in Europe
09:51am, Wednesday, 06'th Mar 2024
Stryker (SYK) completes its first shoulder arthroplasty surgery in Europe using its Blueprint Mixed Reality Guidance system, which aims to benefit shoulder arthroplasty surgeons.
HAE or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 27'th Feb 2024
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two companies is the best option for those looking for unde
Stock Picks For Our Model Portfolio In A Broken Market (Technical Analysis)
09:00am, Tuesday, 20'th Feb 2024
Stock Picks For Our Model Portfolio In A Broken Market (Technical Analysis)
Stryker: Rerating Higher
08:19am, Wednesday, 07'th Feb 2024
Stryker is a leading medical technology company with a diversified product portfolio that targets orthopedic surgery amongst other end markets. Stryker is currently reaping the rewards of a decade of
Stryker: A Dividend Growth Powerhouse I'd Like To Own
08:00am, Friday, 02'nd Feb 2024
Superb quality often comes with a price, which is a lesson that I learned with Stryker. The medtech giant's net sales and adjusted diluted EPS both climbed at double-digit clips in Q4. Stryker earns a
Stryker CEO Kevin Lobo on M&A goals in 2024
12:44pm, Wednesday, 31'st Jan 2024
Stryker CEO Kevin Lobo joins 'Money Movers' to discuss the company's quarterly earnings results, what offensive M&A could look like for Stryker, and what's driving the company's organic growth.
Stryker's (SYK) Q4 Earnings & Revenues Surpass Estimates
11:50am, Wednesday, 31'st Jan 2024
Stryker's (SYK) fourth-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increased, with earnings and revenues beating estimates.
4 med tech stocks with improving prognosis for 2024
07:20am, Wednesday, 31'st Jan 2024
Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to dissipate,
Stryker Corporation (SYK) Q4 2023 Earnings Call Transcript
09:28pm, Tuesday, 30'th Jan 2024
Stryker Corporation (SYK) Q4 2023 Earnings Call Transcript
Stryker (SYK) Reports Q4 Earnings: What Key Metrics Have to Say
07:36pm, Tuesday, 30'th Jan 2024
The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Stryker (SYK) Surpasses Q4 Earnings and Revenue Estimates
06:16pm, Tuesday, 30'th Jan 2024
Stryker (SYK) came out with quarterly earnings of $3.46 per share, beating the Zacks Consensus Estimate of $3.27 per share. This compares to earnings of $3 per share a year ago.
Stryker forecasts strong 2024 as uptick in surgeries lift demand for devices
04:49pm, Tuesday, 30'th Jan 2024
Stryker Corp forecast 2024 profit above Wall Street estimates on Tuesday, banking on a post-pandemic pick-up in volume for certain surgical procedures at hospitals to drive sales for its medical and s
Countdown to Stryker (SYK) Q4 Earnings: Wall Street Forecasts for Key Metrics
10:20am, Thursday, 25'th Jan 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Stryker (SYK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
3 Robotics Stocks to Buy and Hold Forever: January 2024
11:25am, Wednesday, 24'th Jan 2024
The robotics sector is on the brink of an extraordinary boom, with MarketsandMarkets projecting its value to skyrocket from $17.0 billion in 2023 to $32.5 billion by 2028. This steep ascent is just th
